Search for: "Innovation Labs" Results 1081 - 1100 of 1,867
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Aug 2007, 1:44 am
One protest was brought by Linden Labs' decision to potentially "tax" revenue obtained by in-game businesses, after all the profits are based on an environment created by the service provider. [read post]
16 Oct 2018, 7:00 am by Bob Ambrogi
The game, called Learned Hands, is a joint project of Suffolk Law School’s Legal Innovation and Technology Lab, led by David Colarusso, and Stanford Law School’s Legal Design Lab, led by Margaret Hagan, with funding from The Pew Charitable Trusts. [read post]
4 Oct 2023, 10:09 am by Maggie Bailey
To address that knowledge gap, the UNC School of Government Criminal Justice Innovation Lab (the Lab) partnered with the North Carolina Association of Chiefs of Police (NCACP), to execute the Alternative Responder Project. [read post]
14 Jun 2022, 8:55 am by Ethan Rex
The project was supported by The Pew Charitable Trusts and the UNC School of Government Criminal Justice Innovation Lab. [read post]
14 Mar 2025, 3:00 am by Jeff Welty
The Criminal Justice Innovation Lab is seeking a new director. [read post]
28 Apr 2020, 4:00 am by Kari D. Boyle
This is “human-centred design” and is locally showcased and championed by organizations like the CRT, the BC Family Justice Innovation Lab and Access to Justice BC. [read post]
1 Jan 2022, 8:20 am by Rob Robinson
Morgan (Investor)Note: Funding Secured for Working Capital 10-November-21Driven (Merger)Innovative Discovery (Merger) 3-November-21Digital Safe Product Line of Micro FocusSmarshNote: Announced with intent to close in Q1 2022 2-November-21Everlaw (Investee)TPG (Lead) with HIG Growth Partners, Capital G, Menlo Ventures, Andreessen Horowitz and K9 Ventures.Series D Funding for $202,000,000 27-October-21Nextpoint (Investee)Sterling National Bank and Bigfoot Capital (Investors)Note: $4,500,000… [read post]
3 Apr 2019, 6:26 am by Kevin Kaufman
The value of A, representing technology and innovation, is understood to be a residual, which cannot be influenced by policy. [read post]
22 Apr 2011, 11:26 am by Steven Titch
It can be holding that level because low prices and innovative products yield loyal customers. [read post]
16 Apr 2013, 6:37 am by Jeffrey Tignor
Gordon made two excellent points about civic games that I think are also applicable to innovative forms of digital civic engagement more generally. [read post]
31 Jan 2012, 2:41 pm by tahminawatson
The State Department also plans to announce a regulatory change which will enable employees who are intercompany transferees to take advantage of longer visas from the outset of their transfer to the United States Additional Administration commitments to promote startups and small businesses announced today include: • New Challenges Fueling Regional Innovation:  The Department of Commerce’s Economic Development Administration (EDA) is launching the third round of the i6… [read post]
25 Jan 2010, 9:00 am by Lucas A. Ferrara, Esq.
Brookhaven Lab looks forward to contributing to the development of the State's climate action plan. [read post]
19 May 2010, 6:15 am
(Patent Docs) Namenda (Memantine) - Orchid and Forest Labs settle Namenda infringement dispute (Patent Docs) Provigil (Modafinil) – US: FTC wins preliminary battle in anti-trust case against Cephalon in relation to settlement of dispute over Provigil (IP Whiteboard) Skelaxin (Metaxalone) – US: Outstanding Pre-FDAAA citizen petition causes FDA to rule against 180-day exclusivity forfeiture for generic Skelaxin (FDA Law Blog) Solodyn (Minocycline hydrochloride) – US: Ranbaxy… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]